single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	38.18	-5.03	38.94	-0.49	-13.69	0.76	-3.76	-5.03
2023-10-01	2023-12-31	34.62	-7.42	35.62	-0.72	-12.75	1.00	-3.81	-7.42
2023-07-01	2023-09-30	33.22	-7.11	34.66	-0.69	-11.99	1.44	-3.90	-7.11
2023-04-01	2023-06-30	26.04	-7.16	27.04	-0.70	-9.82	1.00	-3.92	-7.16
2023-01-01	2023-03-31	34.08	-2.59	34.81	-0.25	-11.54	0.74	-3.78	-2.59
2022-10-01	2022-12-31	43.74	4.41	44.89	0.43	-12.17	1.16	-3.89	4.41
2022-07-01	2022-09-30	37.09	0.15	37.76	0.01	-10.64	0.67	-4.00	0.15
2022-04-01	2022-06-30	29.67	-2.85	30.32	-0.28	-8.28	0.65	-4.19	-2.85
2022-01-01	2022-03-31	54.39	14.43	54.77	1.52	-11.52	0.38	-5.11	14.43
2021-10-01	2021-12-31	47.29	8.70	47.48	0.84	-9.83	0.20	-3.65	8.70
2021-07-01	2021-09-30	34.91	1.45	35.14	0.14	-8.21	0.23	-3.83	1.45
2021-04-01	2021-06-30	58.84	20.03	59.06	1.95	-8.66	0.22	-3.78	20.03
2021-01-01	2021-03-31	41.21	4.28	41.25	0.59	-7.95	0.04	-3.58	4.28
2020-10-01	2020-12-31	41.86	2.55	42.51	0.27	-16.10	0.65	-3.68	2.55
2020-07-01	2020-09-30	53.76	13.29	54.43	1.43	-15.29	0.67	-3.54	13.29
2020-04-01	2020-06-30	15.22	-6.30	15.91	-0.68	-4.81	0.68	-3.64	-6.30
2020-01-01	2020-03-31	19.68	-13.15	20.37	-1.53	-8.36	0.69	-4.16	-13.15
2019-10-01	2019-12-31	22.20	-10.19	22.91	-1.18	-8.06	0.72	-4.31	-10.19
2019-07-01	2019-09-30	23.25	-8.60	24.00	-1.05	-9.64	0.74	-4.06	-8.60
2019-04-01	2019-06-30	19.03	-10.47	19.77	-1.28	-7.37	0.73	-4.02	-10.47
2019-01-01	2019-03-31	20.77	-12.44	21.52	-1.78	-9.16	0.75	-3.17	-12.44
2018-10-01	2018-12-31	20.81	-12.32	21.52	-1.50	-10.34	0.72	-3.10	-12.32
2018-07-01	2018-09-30	19.98	-13.29	20.54	-	-13.61	0.56	-3.07	-13.29
2018-04-01	2018-06-30	14.82	-13.77	15.32	-	-8.44	0.50	-2.95	-13.77
2018-01-01	2018-03-31	14.73	-13.71	15.41	-	-9.66	0.68	-1.30	-13.71
2017-10-01	2017-12-31	12.62	-13.44	13.05	-	-3.15	0.44	-4.00	-13.44
2017-07-01	2017-09-30	9.79	-14.81	10.39	-	-2.15	0.61	-	-14.81

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	38.18	-5.03	38.94	-0.49	-13.69	0.76	-3.76	-5.03
2023-10-01	2023-12-31	34.62	-7.42	35.62	-0.72	-12.75	1.00	-3.81	-7.42
2023-07-01	2023-09-30	33.22	-7.11	34.66	-0.69	-11.99	1.44	-3.90	-7.11
2023-04-01	2023-06-30	26.04	-7.16	27.04	-0.70	-9.82	1.00	-3.92	-7.16

Compounded Sales Growth
10 Years:	0%
5 Years:	12%
3 Years:	-5%
TTM:	-9%

Compounded Profit Growth
10 Years:	0%
5 Years:	8%
3 Years:	0%
TTM:	-2867%

Stock Price CAGR
10 Years:	0%
5 Years:	-3%
3 Years:	1%
1 Year:	10%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	0%

Aspira Pathlab & Diagnostics Limited

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table